Cargando…
In-vitro prostate cancer biomarker detection by directed conjugation of anti-PSCA antibody to super paramagnetic iron oxide nanoparticless
Background: The main property of a successful conjugation of antibodies to nanoparticles is keeping the potency of antibody for binding the antigen, and an oriented conjugation can do that. Under such ground, this study was carried out to explore the efficiency of two conjugation methods in binding...
Autores principales: | Shahrabi Farahani, Mahboube, Mohsenzadegan, Monireh, Taeb, Jaleh, Farajollahi, Mohammad M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662544/ https://www.ncbi.nlm.nih.gov/pubmed/31380306 http://dx.doi.org/10.34171/mjiri.33.16 |
Ejemplares similares
-
Optimizing the Preparation Procedure of Recombinant PSCA, as a Practical Biomarker in Prostate Cancer
por: Shahrabi Farahani, Mahboube, et al.
Publicado: (2021) -
Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer
por: Nayerpour dizaj, Tina, et al.
Publicado: (2023) -
Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy
por: Mohsenzadegan, Monireh, et al.
Publicado: (2015) -
Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy
por: Bakhshi, Parisa, et al.
Publicado: (2023) -
Conjugation of Monoclonal Antibodies to Super Paramagnetic Iron Oxide Nanoparticles for Detection of her2/neu Antigen on Breast Cancer Cell Lines
por: Shamsipour, Fereshteh, et al.
Publicado: (2009)